President Dr. Andrew Pecora Speaks at International Vatican Stem Cell Conference
Regional Cancer Care Associates’ President Dr. Andrew Pecora Speaks at International Vatican Stem Cell Conference Dr. Pecora Discussed Research and
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Regional Cancer Care Associates’ President Dr. Andrew Pecora Speaks at International Vatican Stem Cell Conference Dr. Pecora Discussed Research and
Is it Time for a New Direction in Oncology Care?
In case you missed it, two new drugs for multiple myeloma have been approved and are expected to extend life
Regional Cancer Care Associates (RCCA), the largest oncology physician network in New Jersey, is proud to announce that 31 RCCA
There was a time when biology, chemistry, and a little bit of physics led to dramatic changes in healthcare and
OBR sits down with Dr. Andrew Pecora, President, Regional Cancer Care Associates to discuss the formation of the network and
Cancer treatment network seeks to treat patients, control costs
The escalating cost of cancer care delivery, which accounts for $104.1 billion in medical care expenditures1, has become a major
The escalating cost of cancer care delivery, which accounts for $104.1 billion in medical care expenditures, has become a major
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.